Immunogenicity, efficacy, and safety of different dose schedules of human papillomavirus vaccines: a Bayesian network meta–analysis of randomized controlled trials
BackgroundTo enhance global vaccine coverage and reduce costs, Human papillomavirus (HPV) immunization schedules are shifting from the standard three–dose (3D) regimen toward reduced–dose (1D or 2D) schedules. We aimed to evaluate the comparative immun…